1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Rhoen-Klinikum AG

Rhoen-Klinikum AG

RHKJF
Rhoen-Klinikum AGUS flagOther OTC
15.30
USD
- -
- -
1.02BMarket Cap
Rhoen-Klinikum AG
RHKJF
(Other OTC)

Recent

price

15.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
18.45
19.02
20.73
21.81
11.54
15.38
17.57
18.09
18.42
19.48
20.32
20.94
21.6
21.87
23.84
25.47
25.2
Revenue per Share
1.01
1.13
0.65
0.63
9.36
1.19
0.84
0.53
0.73
0.65
0.02
0.42
0.38
0.58
0.65
0.51
0.58
Basic EPS, GAAP
-0.74
-0.47
-0.39
0.33
-0.34
-0.12
-0.07
-0.53
-1.7
-1
0.24
0.29
0.03
0.69
0.85
-0.63
- -
Free Cash Flow per Basic Share
0.3
0.37
0.45
0.25
0.26
0.82
0.8
0.35
0.22
0.29
- -
- -
- -
0.15
- -
0.1
- -
Dividend per Share
2.5
2.5
2.5
2.5
1.4
2.32
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.44
Book Value per Share
8.31
8.92
8.51
10.88
8.29
13.08
14.05
14.2
14.68
15.05
15.07
15.58
16.02
16.5
17.21
17.68
17.37
Tangible Book Value per Share
138
138
138
138
131
72
67
67
67
67
67
67
67
67
67
67
69
Basic Weighted Avg Shares
2,550
2,629
2,865
3,014
1,511
1,108
1,176
1,211
1,233
1,304
1,360
1,402
1,446
1,464
1,596
1,705
1,726
Sales/Revenue/Turnover
7.76
7.55
5.43
5.58
-0.5
8.97
8.98
4.12
5.24
4.21
-0.06
2.12
2.39
2.02
2.35
1.7
2.16
Operating Margin (%)
111
143
140
121
82
52
60
59
61
68
70
70
70
66
63
65
65
Depreciation Expense
140
156
90
87
1,226
85
56
35
49
43
1
28
25
39
43
34
40
Net Income, GAAP
16.56
13.62
19.06
23.51
1.65
3.15
3.66
1.02
18.98
18
37.36
- -
19.89
15.84
19.57
19.28
19.12
Effective Tax Rate (%)
5.48
5.94
3.15
2.88
81.15
7.7
4.8
2.9
3.97
3.32
0.11
2.02
1.74
2.64
2.72
2.02
2.32
Profit Margin (%)
264
397
67
1,522
581
252
203
182
237
301
293
338
398
454
499
549
560
Working Capital
- -
972
773
695
154
14
3
3
104
168
157
156
147
146
115
118
- -
LT Debt
1,495
1,599
1,607
1,667
1,249
1,109
1,113
1,125
1,159
1,186
1,190
1,225
1,251
1,280
1,326
1,352
1,365
Total Equity
11.24
8.26
4.75
5.01
-0.39
7.21
8.56
4.45
4.39
3.37
-0.04
- -
1.94
1.73
2.04
1.56
2.22
Return on Invested Capital (%)
41.47
20.21
8.7
8.82
169.97
25.22
32.45
17.25
19.75
13.47
1.42
- -
7.53
11.56
12.77
10.56
20.43
Return on Capital (%)
40.42
45.17
26.08
25.07
463.16
48.63
33.71
21
29.27
25.85
0.87
16.9
15.02
23.12
25.9
20.59
23.93
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
4
- -
LT Borrowings
- -
111
- -
LT Finance Leases
- -
7
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
67
67
Market Capitalization
880
879
907

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
935
890
915
Cash, Cash Equivalents & STI
597
342
578
Accounts Receivable, Net
272
278
257
Inventories
36
41
43
Total Current Liabilities
399
342
356
Payables & Accruals
- -
- -
- -
ST Debt
- -
4
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.01%
2.58%
1.94%
Free Cash Flow
259.34%
376.42%
-173.25%
Net Income, GAAP
174.38%
376.87%
-20.48%
Sales/Revenue/Turnover
4.43%
4.66%
6.84%
Total Cash Common Dividend
- -
- -
-33%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
383
393
396
425
1,596
2025
415
419
429
443
1,705
2026
436
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.16
0.14
- -
- -
0.65
2025
0.11
0.1
- -
- -
0.51
2026
0.19
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.1
2026
- -
- -
- -
- -
- -
Similar Companies
Stem Cell Authority, Ltd. (SCAL)
C.Q. Pharmaceutical Holding Co., Ltd. (000950.SZ)
Kindstar Globalgene Technology, Inc. (9960.HK)
Universal Health Services, Inc. (UHS)
PT Nitrasanata Dharma Tbk (JECX.JK)
Lana Medical Co. (9587.SR)
Business
Rhoen-Klinikum AG operates as one of Germany's largest private hospital groups, providing inpatient, semi-inpatient, and outpatient healthcare services through acute hospitals, medical care centers, and rehabilitation facilities; its core offerings encompass maximum- and intermediate-care treatments across specialties including general medicine, emergency care, university-linked services at Giessen and Marburg University Hospitals, and specialized centers at sites such as Campus Bad Neustadt, Klinikum Frankfurt (Oder), and Zentralklinik Bad Berka. Founded in 1973 and headquartered in Bad Neustadt an der Saale, the company focuses exclusively on the German market, with primary revenue from Bavaria and Hesse regions, and employs over 18,500 staff serving diverse patient populations through campus-style integrated care models tied to research and universities. In recent developments, Rhoen-Klinikum reported solid 2025 results with third-quarter revenues up 7.8% to contribute toward a full-year target of EUR 1.7 billion, first-half revenues rising 7.5% to EUR 883.5 million amid 1.8% higher patient volumes despite EBITDA pressures from ended energy relief subsidies and rising costs, and CEO Prof. Kaltenbach departed as planned following a successful 2024 financial year; the company also pursues innovation via its Rhoen-Innovations subsidiary investing in early-stage digital health and medtech startups, including a minority stake in software provider Tiplu GmbH, while maintaining strategic ties post-Asklepios Kliniken's prior acquisition of a controlling interest.